Qube Research & Technologies (QRT)
NUVB icon

Qube Research & Technologies (QRT)’s Nuvation Bio NUVB Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.63M Sell
287,221
-1,755,091
-86% -$8.58M ﹤0.01% 2214
2026
Q1 		$8.76M Buy
2,042,312
+761,413
+59% +$4.24M 0.01% 1361
2025
Q4 		$11.5M Buy
+1,280,899
New +$7.93M 0.01% 1259
2024
Q4 		– Sell
-163,450
Closed -$374K – 3719
2024
Q3 		$374K Sell
163,450
-33,567
-17% -$102K ﹤0.01% 2359
2024
Q2 		$575K Buy
+197,017
New +$601K ﹤0.01% 2099
2023
Q4 		– Sell
-11,313
Closed -$15.2K – 4618
2023
Q3 		$15.2K Buy
+11,313
New +$18.8K ﹤0.01% 3222

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DFO
Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Qube Research & Technologies (QRT)'s NUVB Position: Q2 2026 in Review

Qube Research & Technologies (QRT) reduced its Nuvation Bio (NUVB) stake by 86% in Q2 2026, selling an estimated $8.58M and leaving 287,221 shares worth $1.63M. The position accounts for ﹤0.01% of the portfolio, ranked #2214.

Qube Research & Technologies (QRT) first reported a position in NUVB in Q3 2023 and has held it in 6 quarters since. The position peaked at $11.5M in Q4 2025. 244 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

  • Qube Research & Technologies (QRT) held 287,221 shares of Nuvation Bio worth $1.63M as of Q2 2026.
  • Qube Research & Technologies (QRT) sold 1,755,091 Nuvation Bio shares in Q2 2026, an estimated $8.58M.
  • Nuvation Bio made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #2214 holding.
  • Qube Research & Technologies (QRT) first reported a position in Nuvation Bio in Q3 2023 and has held it in 6 quarters since.
  • Qube Research & Technologies (QRT)'s Nuvation Bio position peaked at $11.5M in Q4 2025.
  • 244 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.